If you are seeking for Nutraceutical and Cosmecuetical products featuring natural ingredients believed to have beneficial effects on human health maybe you are seeking the OXIS’ consumer products. OXIS is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress”. That is why it was said it is an Advancing Oxidative Stress Technology. OXIS is also the premiere provider for the potent antioxidant, Ergothioneine and through their patented synthetic manufacturing process remains the only significant commercial source of pure L-Ergothioneine worldwide. OXIS’ consumer products have an L-Ergothioneine (ERGO) as the main key component which is very powerful, multifaceted antioxidant and of course addressed to health concern such as: Brain health. Anti-aging, Inflammation, Detoxification, Immunity against diseases, and Blood sugar regulation.
What is Oxidative Stress and why it is so important to us? Oxidative stress is caused by the unchecked activities of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Both ROS and RNS are highly reactive, unstable molecules that, in healthy cells, are created and neutralized as part of normal cell life. However, if the production of free radicals and ROS/RNS exceeds the body’s natural defense mechanisms, oxidative damage to vital molecules in the body can occur and may lead to cell dysfunction and cell death. Oxidative stress is also caused by inflammation, exposure to cigarette smoke, pollution, UV light, radiation, certain drugs and other conditions. Oxidative stress also increases as we age. OXIS’ goal is to control both direct cellular abnormalities and damage from ROS and RNS. One of ways that this can be accomplished is by using OXIS’s compounds to modulate the activation of certain molecules. BXT-51072 is the compound mentioned. It is a low molecular weight, orally active, organoselenium catalytic mimic of one of the major cellular protective antioxidant enzyme, glutathione peroxidase (GPx) which uses glutathione as substrate. BXT-51072 can be taken orally or administered intravenously.
In 2010, OXIS will launch two products:
- “Ergo-Pur™” – ERGO-Pur is a pure form of our highly potent multifaceted antioxidant which we anticipate will be used in some cases in concert with:
- “Ergo-Plex™” – ERGO-Plex is a combination of ERGO plus other functional nutraceutical ingredients directed at Joint Health.
Other products are being evaluated and will include a line of skin care products. In addition, OXIS will develop other nutraceuticals and functional foods such as nutrition bars, energy beverages and single serve shots that lend themselves to traditional retail distribution. In these cases to improve the research and development and sale of products, OXIS need some potential alliances with highly respected, credible and iconic thought leaders in each product category. Therefore there is no penny stocks are negligible and not worth to OXIS as long as individuals or companies build a meaningful and loyal customer bases.
Recent Comments